Vision loss in patients with giant cell arteritis treated with tocilizumab

OBJECTIVES: Giant cell arteritis (GCA) may lead to vision loss. To what extent tocilizumab (TCZ) is able to prevent vision loss is unknown. The aim was to analyze the occurrence of vision loss in a large GCA cohort treated with TCZ. METHODS: In this observational monocentric study, GCA patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Amsler, Jennifer, Kysela, Iveta, Tappeiner, Christoph, Seitz, Luca, Christ, Lisa, Scholz, Godehard, Stalder, Odile, Kollert, Florian, Reichenbach, Stephan, Villiger, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983214/
https://www.ncbi.nlm.nih.gov/pubmed/33752737
http://dx.doi.org/10.1186/s13075-021-02480-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983214/
https://www.ncbi.nlm.nih.gov/pubmed/33752737
http://dx.doi.org/10.1186/s13075-021-02480-4

Ejemplares similares